RetinaRisk™ is the first validated decision support system for management and follow-up of patients with diabetes or diabetic retinopathy. The objective is to provide point of care risk assessment for eye care specialists and more effective communication with patients and other providers. The RetinaRisk™ system is suitable for use by optometrists, ophthalmologists, primary care physicians, diabetes specialists including diabetes educators, pharmacists, or any health care provider who examines, counsels and/or treats patients with diabetes mellitus. Our decision support system takes into account six primary variables known to affect progression of diabetic retinopathy. Results of clinical examination are combined with these variables to determine individual patient risk and quantitatively demonstrate how improvement of modifiable risk factors (blood glucose, HbA1c, blood pressure) may improve that risk. sleep apnea, diabetic kidney disease, obesity) allows the eye care professional to qualitatively refine patient risk and his/her clinical recommendations. The core of our product is an algorithm developed and validated by Risk Medical Solutions (RMS). RetinaRisk™ was developed by RMS and optometric diabetes specialist, A. Paul Chous, MA, OD, FAAO. The RetinaRisk™ team is qualified, energetic and passionate about great diabetes care, with over 30 years of academic and clinical experience in managing and treating diabetes and diabetic retinopathy. We have a vision to improve diabetes care and delivery by applying technology and epidemiological data to improve outcomes, focus on patients at highest risk, and save money.
